BridgeBio Pharma Inc. monthly returns
BridgeBio Pharma Inc. has averaged 3.18% a month with dividends reinvested, and risen in 54% of months, through November 17, 2026. The table lists the most recent months; the chart, the last 5 years.
Month by month#
Data provided bySource: Twelve Data| Month | Path | Total return |
|---|---|---|
| Nov 2026 | +2.5% | |
| Oct 2026 | +13.9% | |
| Sep 2026 | -14.1% | |
| Aug 2026 | -4.4% | |
| Jul 2026 | +7.5% | |
| Jun 2026 | +12.4% | |
| May 2026 | -6.8% | |
| Apr 2026 | -4.2% | |
| Mar 2026 | +11.7% | |
| Feb 2026 | -14.0% | |
| Jan 2026 | +1.0% | |
| Dec 2025 | +6.2% | |
| Nov 2025 | +15.0% | |
| Oct 2025 | +20.6% | |
| Sep 2025 | +0.3% | |
| Aug 2025 | +9.5% | |
| Jul 2025 | +9.5% | |
| Jun 2025 | +26.1% | |
| May 2025 | -10.7% | |
| Apr 2025 | +11.0% | |
| Mar 2025 | -0.9% | |
| Feb 2025 | +2.0% | |
| Jan 2025 | +24.7% | |
| Dec 2024 | +1.3% | |
| Nov 2024 | +15.7% | |
| Oct 2024 | -8.1% | |
| Sep 2024 | -8.6% | |
| Aug 2024 | +7.3% | |
| Jul 2024 | +2.4% | |
| Jun 2024 | -9.6% | |
| May 2024 | +9.3% | |
| Apr 2024 | -17.1% | |
| Mar 2024 | -9.5% | |
| Feb 2024 | -0.4% | |
| Jan 2024 | -15.1% | |
| Dec 2023 | +40.6% | |
| Nov 2023 | +10.3% | |
| Oct 2023 | -1.3% | |
| Sep 2023 | -11.8% | |
| Aug 2023 | -14.6% | |
| Jul 2023 | +103.5% | |
| Jun 2023 | +25.4% | |
| May 2023 | -5.5% | |
| Apr 2023 | -12.4% | |
| Mar 2023 | +45.2% | |
| Feb 2023 | +23.1% | |
| Jan 2023 | +21.8% | |
| Dec 2022 | -18.7% | |
| Nov 2022 | -10.2% | |
| Oct 2022 | +4.9% | |
| Sep 2022 | -5.3% | |
| Aug 2022 | +21.2% | |
| Jul 2022 | -4.6% | |
| Jun 2022 | +32.9% | |
| May 2022 | -14.8% | |
| Apr 2022 | -21.0% | |
| Mar 2022 | +30.1% | |
| Feb 2022 | -21.0% | |
| Jan 2022 | -40.8% | |
| Dec 2021 | -58.8% | |
| Nov 2021 | -18.0% | |
| Oct 2021 | +5.4% | |
| Sep 2021 | -6.5% | |
| Aug 2021 | -6.2% | |
| Jul 2021 | -12.3% | |
| Jun 2021 | +3.0% | |
| May 2021 | +5.9% | |
| Apr 2021 | -9.2% | |
| Mar 2021 | -12.8% | |
| Feb 2021 | +24.5% | |
| Jan 2021 | -20.2% | |
| Dec 2020 | +41.5% | |
| Nov 2020 | +30.9% | |
| Oct 2020 | +2.3% | |
| Sep 2020 | +25.7% | |
| Aug 2020 | +6.1% | |
| Jul 2020 | -13.7% | |
| Jun 2020 | +11.2% | |
| May 2020 | -3.9% | |
| Apr 2020 | +5.3% | |
| Mar 2020 | -9.0% | |
| Feb 2020 | -7.6% | |
| Jan 2020 | -1.6% | |
| Dec 2019 | +20.9% | |
| Nov 2019 | +28.3% | |
| Oct 2019 | +5.3% | |
| Sep 2019 | -29.6% | |
| Aug 2019 | +3.9% | |
| Jul 2019 | +8.8% | |
| Jun 2019since Jun 27 | -2.1% |
Monthly total return (since Dec 2021)#
BridgeBio Pharma Inc. returns by calendar month#
Every month of every year since 2019, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
November 2026 so far: +2.47% — 6th of 8 Novembers since 2019 at the last close; the average November returned +10.3%.
| Month | −105%0+105% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | -4.3% | -1.6% | 43% | +24.7% 2025 | -40.8% 2022 | |
| Feb | +1.0% | -0.4% | 43% | +24.5% 2021 | -21.0% 2022 | |
| Mar | +7.8% | -0.9% | 43% | +45.2% 2023 | -12.8% 2021 | |
| Apr | -6.8% | -9.2% | 29% | +11.0% 2025 | -21.0% 2022 | |
| May | -3.8% | -5.5% | 29% | +9.3% 2024 | -14.8% 2022 | |
| Jun | +14.5% | +12.4% | 86% | +32.9% 2022 | -9.6% 2024 | |
| Jul | +12.6% | +5.0% | 63% | +103.5% 2023 | -13.7% 2020 | |
| Aug | +2.9% | +5.0% | 63% | +21.2% 2022 | -14.6% 2023 | |
| Sep | -6.2% | -7.5% | 25% | +25.7% 2020 | -29.6% 2019 | |
| Oct | +5.4% | +5.1% | 75% | +20.6% 2025 | -8.1% 2024 | |
| Nov | +10.3% | +15.0% | 71% | +30.9% 2020 | -18.0% 2021 | |
| Dec | +4.7% | +6.2% | 71% | +41.5% 2020 | -58.8% 2021 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from BBIO's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is BridgeBio Pharma Inc.'s average monthly return?
- BridgeBio Pharma Inc. has averaged about 3.18% per month (dividends reinvested), positive in roughly 54% of months. The best month was Jul 2023 (+103.5%) and the worst was Dec 2021 (-58.8%).
